Skip to content

ANGLF

IM Cannabis Corp.

Healthcare · Drug Manufacturers - Specialty & Generic · IL

Ask drillr
Key data
Open
From 52W high
Volume
Market cap
P/E (Fwd)
EV/EBITDA
P/E (TTM)
RSI (14)
1D Return
YTD Return
SummaryUpdated Jun 1, 2026

IM Cannabis Corp. (NASDAQ:IMCC) is an Israeli-based medical cannabis company founded in 2016 that has evolved from a multi-market operator to a focused player in the German and Israeli medical cannabis markets. The company went public in May 2020 and is headquartered in Tel Aviv-Yafo, Israel. After initially expanding into Canada, IM Cannabis has strategically refocused its operations on the more promising European and Middle Eastern markets, particularly capitalizing on Germany's cannabis legalization in April 2024.

Latest newsMore news →